This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Learn various ways to cut costs on a limited budget. Make smarter financial choices and save effectively.
21,848 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Atlantic Home Mortgage unveils LendTrain, an online refinance platform that delivers quick, no-credit-check estimates...
Coke trading steepest premium to Pepsi in years has market watchers asking what’s next. This article breaks down the ...
Jamie Dimon's JPMorgan Chase just delivered a striking quarterly message: big gains in equities trading and a higher ...
This guide helps investors decode Workiva's 2025 earnings landscape. Learn which metrics matter, how to read manageme...
As the renewables wave grows, Clearway Energy (CWEN) stands out with a diversified solar and wind portfolio. This gui...
Mortgage rates have dropped to their lowest level since 2022, easing borrowing costs for buyers and signaling renewed...
Viking Holdings (VIK) 2025 reveals how the company navigated a mixed year. This analysis breaks down Q4 results, marg...
Oil prices surged as tensions with Iran intensified, signaling higher pump costs for consumers. Analysts warn househo...
Alcoa reports strong 2025 cash flow and earnings while planning to monetize smelting assets, set against a cooling en...
Banks have ceded mortgage origination and servicing to independent lenders by 2026. Regulators and analysts are weigh...
Rivian has faced a choppy 2026 after huge 2025 gains. This piece explains why april could turning point for Rivian in...